IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques


  • 04/05/2017 - Events

    Mutation discovered that, linked with drug, predisposes osteoporosis patients to femur fracture

    Researchers at the Hospital del Mar Medical Research Institute (IMIM) and the University of Barcelona have uncovered a mutation that makes bone vulnerable to bisphosphonates, drugs used to combat osteoporosis. Instead of strengthening bone and preventing fractures, these medicines induce a critical problem that makes the femur more prone to breaks. This discovery, enormously significant clinically, was published today in the New England Journal of Medicine, the most important biomedical journal in terms of potential impact. Osteoporosis causes fractures that affect up to 40% of people over the age of 50. Bisphosphonates are efficient and cheap, making them the first line of treatment for this condition. Nevertheless, they have been associated with atypical fracturing of the femur. "Despite the rarity of this complication and the fact that many more fractures are prevented than induced, fear of this complication has led to the prescription of these drugs being criticised, especially for long-term treatment", explains study leader Dr. Adolf Díez, emeritus head of internal medicine at Hospital del Mar and a researcher in the musculoskeletal research group at the IMIM. 

    Més informació "Mutation discovered that, linked with drug, predisposes osteoporosis patients to femur fracture"

  • 26/05/2016 - Events

    Biomarker discovered that measures the risk of cancer in non-smokers

    Researchers from the Hospital del Mar Medical Research Institute (IMIM) have, for the first time, demonstrated that measurements of a tobacco-specific nitrosamine in the hair, NNK, correlate with the real risk of exposure to the carcinogens in tobacco smoke in passive smokers. This substance is a much better biomarker than any of the markers measured up to now for assessing this risk and it has been found in higher concentrations in the hair than any other tobacco-specific carcinogen. The study was conducted in collaboration with researchers at the Catalan Institute of Oncology (ICO) and has been published in the journal Scientific Reports. The smoke passive smokers are exposed to differs from the smoke of smokers. Passive smokers are exposed to a lot of chemicals resulting from the combustion of the cigarette, but in addition, certain substances have gone through various activation reactions, making them carcinogenic.

    Més informació "Biomarker discovered that measures the risk of cancer in non-smokers"

  • 25/05/2016 - Events

    New evidence on molecular mechanisms involved in psoriasis outset

    Two translational research studies by the University of Barcelona have described new immunologic mechanisms in psoriasis, a chronic cutaneous inflammatory disease which affects around the 2% of the population. The studies, published in the high impact scientific magazines Journal of Allergy and Clinical Immunology and Journal of Investigative Dermatology , have analysed the molecular processes involved in the IL-17 cytokine –a protein family of the immune system- with samples of patients with psoriasis. These results are important to understand the origins of psoriasis and develop more specific pharmaceutical treatments, since the IL-17 blocking is a new therapeutic strategy which is very effective when controlling this illness. The studies have been led by Lluís Francesc Santamaria, Director of the group of Translationary Immunology of the University of Barcelona based at the Barcelona Science Park, together with researchers of the Hospital del Mar and the Municipal Institute for Medical Research, among others.

    Més informació "New evidence on molecular mechanisms involved in psoriasis outset"

  • 09/05/2014 - Events

    GPCR Spring Conference 2014

    Understanding the complex nature of G protein-coupled receptors (GPCR) functionality and exploiting this knowledge for the design of new GPCR modulators has been the central focus of GPCR Spring Conference 2014 organized by the GRIB (IMIM-UPF) researchers Jana Selent and Maria Martí at Barcelona Biomedical Research Park (Barcelona) from 28-30th April. GPCRs are the largest family of proteins involved in signal transduction across membranes and one of the most important pharmaceutical drug target classes. 

    Més informació "GPCR Spring Conference 2014"

  • 20/12/2011 - Events

    Bidding farewell to the participants of the PREDIMED study

    Last 14th December an event was held at the PRBB Auditorium; it was organized by the IMIM Group on Cardiovascular Risk and Nutrition to say goodbye to and thank the participants in the PREDIMED study, their involvement, availability and enthusiasm during the four years over which the project has developed (2003-2011).

    Més informació "Bidding farewell to the participants of the PREDIMED study"

  • 09/03/2011 - Events

    First international index developed to predict suicidal behavior

    Although thousands of people commit suicide worldwide each year, researchers and doctors do not have any method for evaluating a person's likelihood of thinking about or trying to commit suicide. An international group of scientists, in which the IMIM (Hospital del Mar Research Institute) has participated, has devised the first risk index in order to prevent suicides.

    Més informació "First international index developed to predict suicidal behavior"

  • 16/04/2010 - Events

    The chronic lymphocytic leukaemia project reveals the first oncogenic mutations

    The International Cancer Genome Consortium, which will study the genomes of more than 25,000 cancer patients, has presented its latest research results in the journal Nature. The chronic lymphocytic leukemia genome project is coordinated in Spain, and the researcher Nuria López-Bigas, head of Biomedical Genomics laboratory of GRIB (IMIM-UPF) participates on the bioinformatics analysis of data and the coordination and management of Consortium data.

    Més informació "The chronic lymphocytic leukaemia project reveals the first oncogenic mutations"

  • 30/09/2009 - Events

    Open day at PRBB

    On Saturday, October 3, from 10am to 7pm, we invite the citizens to an educational and joyful Open Day at the Barcelona Biomedical Research Park (PRBB). Visitors can participate in scientific experiments, visit laboratories and installations, watch videos, get to know the lines of research of the park, participate in a round-table discussion and talk to the young scientists who will attend all the questions of the public.

    Més informació "Open day at PRBB"

  • 25 November 2008 - Events

    1st BiblioPRO Appraiser Training Workshop

    The 1st BiblioPRO Appraiser Training Workshop was held on Friday, 21st November. BiblioPRO is an online library which provides exhaustive and high-quality scientific information on health-related quality of life instruments and other Patient Reported Outcomes (PROs) for use in Spain and other Spanish-speaking countries. The aim of the library is to facilitate the appropriate use of these instruments in research, clinical practice, and health care planning and management

    Més informació "1st BiblioPRO Appraiser Training Workshop"

  • Events

    Open Day event at the Barcelona Biomedical

    Discover the science and the real life of researchers in the fascinating elliptical building at the beach of Barcelona. On Saturday, October 4, the large European infrastructure PRBB with more than 1.200 people doing research in biomedicine invites the public to an open day.

    Més informació "Open Day event at the Barcelona Biomedical"


Head of Communications:
Rosa Manaut(ELIMINAR)

Communications office:
Marta Calsina(ELIMINAR)

(+34) 93 316 06 80
(+34) 699 094 833

Doctor Aiguader, 88
08003 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact